Comparison of Interleukin-6 with Other Markers in Diagnosis of Ovarian Cancer
The lack of specific symptoms in ovarian cancer delays onset of the diagnostic process. Hence, most cases are recognized in late stages of the disease. The aim of this study was to confirm the role of Il-6 compared to other markers in diagnosis and survival in ovarian cancer. The database was collec...
Main Authors: | Magdalena Bizoń, Zofia Awiżeń-Panufnik, Włodzimierz Sawicki |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/13/6/980 |
Similar Items
-
Elevated Interleukin-6 Levels in the Circulation and Peritoneal Fluid of Patients with Ovarian Cancer as a Potential Diagnostic Biomarker: A Systematic Review and Meta-Analysis
by: Hina Amer, et al.
Published: (2021-12-01) -
Biochemical markers of ovarian stromal cell tumors
by: A. M. Beishembaev
Published: (2021-11-01) -
Evaluation of the level of the inflammatory factor interleukin-6 in patients with polycystic ovaries and insulin resistance
by: Zahraa Emad Hussein, et al.
Published: (2023-01-01) -
COVID-19 and cytokine storm syndrome: can what we know about interleukin-6 in ovarian cancer be applied?
by: Antonio Macciò, et al.
Published: (2021-02-01) -
A nomogram model based on clinical markers for predicting malignancy of ovarian tumors
by: Bingsi Gao, et al.
Published: (2022-11-01)